Roche Holding AG

04/15/2024 | Press release | Distributed by Public on 04/15/2024 11:58

[Ad hoc announcement pursuant to Art. 53 LR] Roche’s Columvi meets primary endpoint of overall survival in people with relapsed or refractory diffuse large B-cell lymphoma in[...]